Prof. Bastiaan Bloem discusses the latest developments in biomarkers and treatments for movement disorders, which have been described in numerous research papers from 2022.
Show references: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(22)00494-X/fulltext
